Biomarker: | ER positive |
---|---|
Cancer: | Estrogen Receptor Positive Breast Cancer |
Drug: | everolimus (mTOR inhibitor) + Piqray (alpelisib) (PI3Kα inhibitor) + Verzenio (abemaciclib) (CDK4/6 inhibitor) + Inluriyo (imlunestrant) (Selective estrogen receptor degrader) |
Direction: | Sensitive |